A detailed history of Ronald Blue Trust, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 1,959 shares of INSM stock, worth $139,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,959
Previous 80 2348.75%
Holding current value
$139,598
Previous $5,000 2760.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$62.0 - $79.01 $116,498 - $148,459
1,879 Added 2348.75%
1,959 $143,000
Q2 2024

Jul 18, 2024

BUY
$22.0 - $69.71 $1,760 - $5,576
80 New
80 $5,000
Q4 2023

Jan 18, 2024

BUY
$23.42 - $31.74 $889 - $1,206
38 New
38 $1,000
Q2 2023

Jul 14, 2023

BUY
$16.44 - $21.1 $131 - $168
8 New
8 $0
Q3 2022

Oct 21, 2022

BUY
$20.88 - $28.21 $626 - $846
30 New
30 $1,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.65B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.